Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 30 days ( 0 % )
Last Price $1.90 0 %
High/ Low $1.90 - $1.90 0%
Chg 7 Days N/A $1.90 $1.90
Chg 30 Days N/A $1.90 $1.90
Chg 12 mos -6.40 % $2.03 $1.90
Trend - 3 mos 15.90 % Width: 23.12 %
Trend - 12 mos 14.87 % Width: 64.77 %
Pred. range - 3 mos $2.15 - $2.64 12.97 % - 39.09 %
Pred. range - 12 mos $1.49 - $2.45 -21.64 % - 29.11 %
Short MA avg 3 mos Buy May 31, 2024 - 34 days
Long MA avg 3 mos Sell May 28, 2024 - 37 days
Short/Long MA avg 3 mos Buy May 14, 2024 - 46 days
Short MA avg 12 mos Buy May 31, 2024 - 34 days
Long MA avg 12 mos Sell May 28, 2024 - 37 days
Short/Long MA avg 12 mos Buy May 22, 2024 - 40 days
Pivot Short Sell Jul 17, 2024 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and ... LIFE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT